Clinical characteristics of 273 study participants
| Variable | n (%) |
| Age, years, mean±SD | 51±16 |
| Male sex (%) | 161 (59) |
| BMI, kg/m2, mean±SD | 22.72±4.62 |
| Disease extent (pancolitis/left-sided/proctitis/others) | 113/74/79/7 |
| Disease duration, years, median±IQR | 7±11 |
| Medications | |
| 5-aminosalicylates (%) | 249 (91.2) |
| Prednisolone (%) | 59 (21.6) |
| TNF-α monoclonal antibody (%) | 17 (6.2) |
| Azathioprine (%) | 45 (15.5) |
| Clinical remission, % | 158 (57.9) |
| Mayo endoscopic subscore (MES), mean±SD | 1.18±0.91 |
| MES 0, n (%) | 71 (26) |
| MES 1, n (%) | 101 (37) |
| MES 2, n (%) | 81 (29.7) |
| MES 3, n (%) | 20 (7.3) |
| Partial mucosal healing (MES ≤1) (%) | 172 (63) |
| Mucosal healing (MES=0) (%) | 71 (26) |
| Albumin, g/dL, mean±SD | 4.21±0.43 |
| CRP, mg/dL, median±IQR | 0.099±0.23 |
BMI, body mass index; CRP, C reactive protein; TNF, tumour necrosis factor.